Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cascades ( (TSE:CAS) ) has issued an announcement.
Cascades Inc. reported its second-quarter financial results for 2025, highlighting a slight increase in sales to $1,187 million and an adjusted EBITDA of $137 million. Despite a net loss per share, the company saw improvements in operating income and a reduction in net debt. The packaging segment benefited from price increases and stable shipments, while the tissue segment maintained stable results despite higher operational costs. The company anticipates a slightly better performance in the third quarter, with stable packaging results and stronger tissue performance expected.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$12.50 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Spark’s Take on TSE:CAS Stock
According to Spark, TipRanks’ AI Analyst, TSE:CAS is a Neutral.
Cascades’ overall stock score reflects resilient operational performance with stable revenue growth and solid cash flow management. However, profitability issues and a negative P/E ratio create valuation challenges. Technical indicators suggest cautious sentiment, while recent corporate actions highlight efforts to improve financial flexibility. The earnings call provided a mixed outlook, with strategic initiatives offering future potential but immediate challenges remaining.
To see Spark’s full report on TSE:CAS stock, click here.
More about Cascades
Cascades Inc. operates in the packaging and tissue paper industry, focusing on producing sustainable packaging solutions and tissue products. The company is known for its commitment to environmental responsibility and innovation in the paper and packaging sector.
Average Trading Volume: 283,799
Technical Sentiment Signal: Sell
Current Market Cap: C$917.4M
For a thorough assessment of CAS stock, go to TipRanks’ Stock Analysis page.